Mortality risks in gay men with human immunodeficiency virus infection and cognitive impairment

We obtained data from 111 gay men who entered a longitudinal study of the natural history of human immunodeficiency virus (HIV) without clinical evidence of acquired immunodeficiency syndrome (AIDS), and examined them regularly over a 36-month period. Using a Cox proportional-hazard regression model to compare cumulative risk of mortality in subjects with and without cognitive impairment and several putative risk factors present at baseline, we found that the mortality risk ratio (RR) associated with poor neuropsychologic test performance was significantly increased (RR = 2.9; 95% confidence interval [CI], 1.1 to 7.8), and increased further (RR = 4.1; 95% CI, 1.3 to 12.5) when adjusted for other factors associated with mortality (a history of a disturbance in movement or gait, CD4-lymphocyte and red blood-cell counts, and age). A significant increase in symptoms related to cognitive impairment and gait, a decline in neuropsychologic test performance, and declines in CD4-lymphocyte and red-cell counts occurred over the study period. A second model was constructed to adjust for changes in CD4-lymphocyte and red-cell counts, age, medical stage, and motor symptoms over the study period, but the mortality RR for poor neuropsychologic test performance at baseline changed very little (RR = 4.7; 95% CI, 1.5 to 14.9). We conclude that the presence of cognitive impairment, manifest by poor neuropsychologic test performance in both asymptomatic and symptomatic gay men with HIV infection, is associated with a significantly increased risk of death. This effect progresses in parallel with the immunologic and systemic effects of HIV.

[1]  C. Stefanis,et al.  Neuropsychological assessment of HIV-seropositive haemophiliacs. , 1991, AIDS.

[2]  M. Weil,et al.  Long-term survival of patients with AIDS, Pneumocystis carinii pneumonia, and respiratory failure. , 1991, JAMA.

[3]  R. Chaisson,et al.  Zidovudine and the natural history of the acquired immunodeficiency syndrome. , 1991, The New England journal of medicine.

[4]  M Susser,et al.  What is a cause and how do we know one? A grammar for pragmatic epidemiology. , 1991, American journal of epidemiology.

[5]  J. Fleishman,et al.  Patterns of survival with AIDS in the United States. , 1991, Health services research.

[6]  J. Gorman,et al.  Sexual risk behavior, sexual functioning, and HIV‐disease progression in gay men , 1991 .

[7]  E. Werner,et al.  Negative correlation between blood cell counts and serum neopterin concentration in patients with HIV-1 infection. , 1991, AIDS.

[8]  D. Griffin,et al.  Neopterin and interferon‐gamma in serum and cerebrospinal fluid of patients with HIV‐associated neurologic disease , 1991, Neurology.

[9]  K. Marder,et al.  Multidisciplinary baseline assessment of gay men with and without HIV infection: III. neurological and neuropsychological findings. , 1991 .

[10]  N. Adachi.  Beta-2-Microglobulin Levels in the Cerebrospinal Fluid: Their Value as a Disease Marker , 1991 .

[11]  C Eisdorfer,et al.  Cognition in early human immunodeficiency virus infection. , 1990, Archives of neurology.

[12]  M. Farinelli,et al.  Study of beta-2 microglobulin and neopterin in serum and cerebrospinal fluid of HIV-infected patients. , 1990, Acta neurologica.

[13]  J. Phair,et al.  Low prevalence of neurological and neuropsychological abnormalities in otherwise healthy HIV‐1–infected individuals: Results from the multicenter AIDS cohort study , 1989, Annals of neurology.

[14]  R. Chaisson,et al.  Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort , 1988, British medical journal.

[15]  J. McArthur.  Neurologic Manifestations of AIDS , 1987, Medicine.

[16]  J. Phair,et al.  Infection with the human immunodeficiency virus: clinical manifestations and their relationship to immune deficiency. A report from the Multicenter AIDS Cohort Study. , 1987, Annals of internal medicine.

[17]  Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Council of State and Territorial Epidemiologists; AIDS Program, Center for Infectious Diseases. , 1987, MMWR supplements.

[18]  B. Navia,et al.  The acquired immunodeficiency syndrome dementia complex as the presenting or sole manifestation of human immunodeficiency virus infection. , 1987, Archives of neurology.

[19]  K Y Liang,et al.  Longitudinal data analysis for discrete and continuous outcomes. , 1986, Biometrics.

[20]  Mm. Liabre.  Standard Progressive Matrices , 1984 .

[21]  D. Crockett.  A comparison of empirically derived groups of aphasic patients on the Neurosensory Center Comprehensive Examination for Aphasia. , 1977, Journal of clinical psychology.

[22]  HERMAN BUSCHKE,et al.  Evaluating storage, retention, and retrieval in disordered memory and learning , 1974, Neurology.

[23]  I. T. Draper.  THE ASSESSMENT OF APHASIA AND RELATED DISORDERS , 1973 .

[24]  J. Fleiss,et al.  Statistical methods for rates and proportions , 1973 .

[25]  J. Peto,et al.  Asymptotically Efficient Rank Invariant Test Procedures , 1972 .

[26]  M. Graffar.  [Modern epidemiology]. , 1971, Bruxelles medical.

[27]  N. Mantel.  Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.

[28]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[29]  D.,et al.  Regression Models and Life-Tables , 2022 .